Bøgesø KP, Liljefors T, Arnt J, Hyttel J, Pedersen H (tháng 7 năm 1991). “Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonists”. Journal of Medicinal Chemistry. 34 (7): 2023–30. doi:10.1021/jm00111a015. PMID1676758.
Kristensen JL, Püschl A, Jensen M, và đồng nghiệp (tháng 10 năm 2010). “Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors”. Journal of Medicinal Chemistry. 53 (19): 7021–34. doi:10.1021/jm100652h. PMID20857909.
Liljefors T, Bøgesø KP (tháng 2 năm 1988). “Conformational analysis and structural comparisons of (1R,3S)-(+)- and (1S,3R)-(−)-tefludazine, (S)-(+)- and (R)-(−)-octoclothepin, and (+)-dexclamol in relation to dopamine receptor antagonism and amine-uptake inhibition”. Journal of Medicinal Chemistry. 31 (2): 306–12. doi:10.1021/jm00397a006. PMID2892932.
nih.gov
pubmed.ncbi.nlm.nih.gov
Metysová J, Metys J, Dlabac A, Kazdová E, Valchár M (1980). “Pharmacological properties of a potent neuroleptic drug octoclothepin”. Acta Biologica et Medica Germanica. 39 (6): 723–40. PMID6893891.
Melich H (1971). “[Clotepin]”. Cas. Lek. Cesk. (bằng tiếng Séc). 110 (17): 404–5. PMID5576292.
Campiani G, Butini S, Gemma S, và đồng nghiệp (tháng 1 năm 2002). “Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents. Synthesis, structure-activity relationship, molecular modeling, and biological studies”. Journal of Medicinal Chemistry. 45 (2): 344–59. doi:10.1021/jm010982y. PMID11784139.
Bøgesø KP, Liljefors T, Arnt J, Hyttel J, Pedersen H (tháng 7 năm 1991). “Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonists”. Journal of Medicinal Chemistry. 34 (7): 2023–30. doi:10.1021/jm00111a015. PMID1676758.
Kristensen JL, Püschl A, Jensen M, và đồng nghiệp (tháng 10 năm 2010). “Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors”. Journal of Medicinal Chemistry. 53 (19): 7021–34. doi:10.1021/jm100652h. PMID20857909.
Liljefors T, Bøgesø KP (tháng 2 năm 1988). “Conformational analysis and structural comparisons of (1R,3S)-(+)- and (1S,3R)-(−)-tefludazine, (S)-(+)- and (R)-(−)-octoclothepin, and (+)-dexclamol in relation to dopamine receptor antagonism and amine-uptake inhibition”. Journal of Medicinal Chemistry. 31 (2): 306–12. doi:10.1021/jm00397a006. PMID2892932.